Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
No Data
Revenue and Profits:
Net Sales:
671 Million
(Quarterly Results - Mar 2026)
Net Profit:
86 Million
Pharmaceuticals & Biotechnology
PLN 5,911 Million (Mid Cap)
22.00
NA
0.00%
1.21
-999,999.00%
9.78






